This inventor holds 5 USPTO granted patents. Top assignee: Wockhardt Limited. Active years: 2003-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cidco Aurangabad, IN (2005 - 2008)
- Aurangabad, IN (2003 - 2009)
Company Filing History:
Years Active: 2003-2009
Title: Shiv Kumar Agarwal: Innovator in Antimicrobial Research
Introduction
Shiv Kumar Agarwal is a prominent inventor based in Aurangabad, India. He has made significant contributions to the field of antimicrobial research, holding a total of 5 patents. His work focuses on developing innovative solutions to combat bacterial infections.
Latest Patents
One of Agarwal's latest patents is titled "Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments." This invention relates to new generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, including their optical isomers, diastereomers, or enantiomers. It also covers pharmaceutically acceptable salts, hydrates, prodrugs, polymorphs, and pseudopolymorphs, along with their preparation, compositions, and uses.
Career Highlights
Agarwal is currently associated with Wockhardt Limited, a leading pharmaceutical company. His work at Wockhardt has allowed him to focus on the development of novel antimicrobial agents that can address the growing issue of antibiotic resistance.
Collaborations
Some of his notable coworkers include Noel John De Souza and Mahesh Vithalbhai Patel. Their collaborative efforts have contributed to the advancement of research in the field of antimicrobial medications.
Conclusion
Shiv Kumar Agarwal's innovative work in antimicrobial research highlights his commitment to improving healthcare through scientific advancements. His contributions are paving the way for new treatments that can effectively combat bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
